THE ROLE OF ANDROGENS IN ENSURING SEXUAL FUNCTION IN MEN
DOI:
https://doi.org/10.21856/j-PEP.2010.1.15Keywords:
Sexy function of a manAbstract
Sexy function of a man is a multifaceted and includes interaction between nervous, endocrine Noah and vascular systems, as well as mi structures that contribute to fishing, communicating and satisfying rhenium.
References
Bancroft J. The biological basis of human sexuality [Text] / J. Bancroft // Human Sexuality and its problems. — Edinburgh: Churchill Livingstone, 1989. — P. 12– 127.
Kandeel F. R. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment [Text] / F. R. Kandeel, K. T. Vivien Koussa, R. S. Swerdloff // Endocr. Rev. — 2001. — Vol. 22, № 3. — P. 342–388.
Bancroft J. The endocrinology of sexual arousal [Text] / J. Bancroft // J. Endocrin. — 2005. — Vol. 186. —P. 411–427.
Wilson J. D. The Role of Androgens in Male Gender Role Behavior [Text] / J. D. Wilson // Endocrin. Rev. — 1999. — Vol. 20, № 5. —P. 726–737.
Bagatell C. J. Androgens in men –uses and abuses [Text] / C. J. Bagatell, W. J. Bremner // N. Engl. J. Med. — 1996. —Vol. 334, № 11. —P. 707–714.
Kumar A. Biology of Sexual Dysfunction [Text] / A. Kumar, N. B. Pai, S. Rao [et al.] // O. J. H. A. S. — 2009. — Vol. 8, Issue 1. —P. 1–7.
Нишлаг Э. Андрология. Мужское здоровье и дисфункция репродуктивной системы [Teкст] / под ред. Э. Нишлага, Г. М. Бере; пер. с англ. — М.: Медицинское информационное агентство, 2005. — 551 с.
Kaufman J. M. The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications [Text] / J. M. Kaufman, A. Vermeulen // Endocrin. Rev. — 2005. —Vol. 26, № 6. — P. 833–876.
Morales A. Endocrine Aspects of Sexual Dysfunction in Men [Text] / A. Morales, J. Buvat, L. J. Gooren [et al.] / J. Sex. Med. — 2004. —Vol. 1, Issue 1. —P. 69–81.
Burnett A. L. Neurophysiology of Erectile Function: Androgenic Effects [Text] / A. L. Burnett // J. Androl. — 2003. — Vol. 24, № 6. — P. 2–5.
Stief C. Testosterone and Erection: Practical Management for the Patient with Erectile Dysfunction [Text] / C. Stief // Europ. Urol. Suppl. — 2007. — Vol. 6. — P. 868–873.
Everitt B. J. Neuroendocrine mechanisms underlying appetitive and consummatory elements of masculine sexual behavior [Text] / B. J. Everitt // The pharmacology of sexual function and dysfunction. — Amsterdam, 1995. — P. 15–31.
Puy L. Immunocytochemical detection of androgen receptor in human temporal cortex characterization and application of polyclonal androgen receptor antibodies in frozen and paraffinembedded tissues [Text] / L. Puy, N. J. MacLusky, L. Becker // J. Steroid. Biochem. Mol. Biol. — 1995. — Vol. 55, Issue 2. — P. 197–209.
Breedlove S. M. Hormone accumulation in a sexually dimorphic motor nucleus of the rat spinal cord [Text] / S. M. Breedlove, A. P. Arnold // Science. — 1980. — Vol. 210, Issue 4469. —P. 564–566.
Dail W. G. The major pelvic ganglion in the pelvic plexus of the male rat: a histochemical and ultrastructural study [Text] / Dail W. G., Evan A. P., Eason H. R. // Cell and Tiss. Res. — 1975. — Vol. 159, № 1. —P. 49–62.
Melvin J. E. The major pelvic ganglion: androgen control of postnatal development [Text] / J. E. Melvin, R.W. Hamill // J. Neurosci. — 1987. — Vol. 7. —P. 1607– 1612.
Burnett A. L. Role of nitric oxide in the physiology of erection [Text] / A. L. Burnett // Biol. Reprod. — 1995. — Vol. 52, № 3. — P. 485–489.
Gooren J. G. Recent insights into androgen action on the anatomical and physiological substrate of penile erection [Text] / J. G. Gooren, F. Saad // Asian J. Androl. — 2006. — Vol. 8, № 1. — P. 3–9.
Горпинченко И. И. Лечение эректильной дисфункции [Teкст] / под ред. И. И. Горпинченко. —К.: издательский дом «Профессионал», 2008. — 191 с.
Musicki B. eNOS Function and Disfunction in the Penis [Text] / B. Musicki, Burnett A. L. // Exp. Biol. Med. — 2006. —Vol. 231, № 2. — P. 154–165.
Vignozzi L. Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes [Text] / L. Vignozzi, A. Morelli, S. J. Filippi [et al.] // J. Sex. Med. — 2007. — Vol. 4. —P. 620–632.
Traish A. M. Testosterone and Erectile Function: From Basic Research to a New Clinical Paradigm for Managing Men with Androgen Insufficiency and Erectile Dysfunction [Text] / A. M. Traish, I. Goldstein, N. N. Kim // Europ. Urol. —2007. — Vol. 52, Issue 1. — P. 54–70.
Komesaroff P. A. Aromatase inhibition alters vascular reactivity and arterial compliance in men: A possible vascular role for endogenous sex hormones in men [Text] / P. A. Komesaroff, R. Murray, C. R. Kumar [et al.] // Austral. and N. Z. J. Med. —1999. — Vol. 29, № 2. — P. 265–267.
Караченцев А. Н. Вазоактивные эффекты половых гормонов [Teкст] / А. Н. Караченцев, П. В. Сергеев // Пробл. Эндокринол. —1997. — Т. 43, № 2. — С. 42–45.
Korenman S. G. Secondary hypogonadism in older men: its relation to impotence [Text] / S. G. Korenman, J. E. Morley, A. D. Mooradian [et al.] // J. Clin. Endocr. Metab. — 1990. — Vol. 71, № 4. —P. 963–969.
Nasser M. Does Testosterone Have a Role in Erectile Function? [Text] / M. Nasser // Americ. J. Med. — 2006. — Vol. 119, Issue 5. —P. 373-382.
NIH Consensus Development Panel on Impotence [Text] // JAMA. — 1993. — Vol. 270, № 1. — P. 83–90.
Arver S. Current Guidelines for the Diagnosis of Testosterone Deficiency [Text] / S. Arver, M. Lehtihet // Advances in the Management of Testosterone Deficiency. Front Horm Res. —Basel, Karger, 2009. — Vol. 37. — P. 5– 20.
Yassin A. A. Testosterone and Erectile Dysfunction. Review [Text] / A. A. Yassin, Saad F. // J. Androl. — 2008. —Vol. 29, № 6. —P. 593–604.
Kim Y. C. Endocrine and metabolic aspects, including treatment in Erectile Dysfunction [Text] / Y. C. Kim, J. Buvat, C. C. Carson [et al.] // Erectile Dysfunction, 1st international consultation on erectile dysfunction, Paris, July 1–3, 1999. —un vol., Health Publications Ltd, 2000.
Buvat J. Endocrine screening in 1022 men with erectile dysfunction: clinical significance and cost-effective strategy [Text] / J. Buvat, A. Lemaire // J. Urol. —1997. — Vol. 158, № 5. — P. 1764–1767.
Manieri C. Hormonal control of sexual behavior in males and endocrinologic causes of sexual dysfunction [Text] / C. Manieri, C. Di Bisceglie, M. Tagliabue [et al.] // Minerva Endrocrinol. —1997. — Vol. 22, № 2. — P. 37–43.
O’Carroll R. Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled study [Text] / R. O’Carroll, J. Bancroft // Brit. J. Psychiatr. — 1984. — Vol. 145. —P. 146–151.
Carania C. Testosterone and prolactin: behavioural and psychophysiological approaches in men [Text] / C. Carania, D. Zini, A. Baldini [et al.] // The pharmacology of sexual function and dysfunction: esteve foundation symposia, Amsterdam. — Excepta Medica. —1995. — Vol. 6. —P. 145–150.
Rosen R. C. Pharmacological effects on Nocturnal Penile Tumescence (NPT) [Text] / R. C. Rosen // The pharmacology of sexual function and dysfunction: esteve foundation symposia, Amsterdam. — Excepta Medica. —1995. — Vol. 6. —P. 277–287.
Burris A. S. A long term prospective study of the physiology and behavioural effects of hormone replacement in untreated hypogonadal men [Text] / A. S. Burris, S. M. Banks, C. S. Carter [et al.] // J. Androl. — 1992. — Vol. 13, Issue 4. —P. 297–304.
Park K. A new potential of blood oxygenation level dependent (BOLD) functional MRI for evaluating cerebral centers of penile erection [Text] / K. Park, J. J. Seo, H. K. Kang [et al.] // Int. J. Impot. Res. — 2001. — Vol. 13, № 2. —P. 73–81.
Diagnosis and Treatment of Erectile Disfunction [Text] / A. Tsertsvadze, F. Yazdi, A. H. Fink et al. [et al.] // — Evidence Report/Technology Assessment, № 171. —Ottawa, Canada: University of Ottawa Evidencebased Practice Center, 2009. — 230 p.
Araujo A. B. Prevalence of Symptomatic Androgen Deficiency in Men [Text] / A. B. Araujo, G. R. Esche, V. Kupelian [et al.] // J. Clin. Endocrinol. Metab. — 2007. — Vol. 92, № 11. —P. 4241–4247.
Gades N. M. The associations between serum sex hormones, erectile function, and sex drive: the Olmsted County study of urinary symptoms and health status among men [Text] / N. M. Gades, D. J. Jacobson, M. E. McGree [et al.] // J. Sex. Med. — 2008. — Vol. 5, № 9. — P. 2209–2220.
Аляев Ю. Г. Нарушение половой и репродуктивной функции у мужчин [Teкст] / Ю. Г. Аляев, В. А. Григорян, М. Е. Чалый. — М.: Литтера, 2006. — 188 с.
Минухин А. С. Показатели андрогенизации у мужчин молодого возраста с различным состоянием эректильной функции [Teкст] / А. С. Минухин, В. А. Бондаренко // Здоровье мужчины. — 2009. — № 2. — С. 63–65.
Rosen R. C. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction [Text] / R. C. Rosen, J. C. Cappelleri, M. D. Smith [et al.] // Int. J. Impot. Res. — 1999. — Vol. 11, № 6. — P. 319–326.
Aversa A. Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction [Text] / A. Aversa, A. Isidori, M. De Martino [et al.] // Clin. Endocrinol. — 2000. — Vol. 53, № 4. — P. 517–522.
Bolona E. R. Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials [Text] / E. R. Boloca, M. V. Uraga, R. M. Haddad et [et al.] // Mayo Clin. Proc. — 2007. — Vol. 82, № 1. —P. 20–28.
Lee K. K. Simple Self-Report Diary for Assessing Psychosexual Function in Hypogonadal Men [Text] / K. K. Lee, N. Berman, G. M. Alexander [et al.] // J. Androl. — 2003. —Vol. 24, № 5. —P. 688–698.
Минухин А. С., Бондаренко В. А. Опыт применения гелиевой формы тестостерона при терапии эректильной дисфункции у мужчин с гипоандрогенным статусом [Teкст] / А. С. Минухин, В. А. Бондаренко // Здоровье мужчины. — 2009. — № 3. — С. 27–28.
Ming J. A research on the relationship between ejaculation and serum testosterone level in men [Text] / J. Ming, J. Xin, Z. Qiang, S. Jin-wen // J. Zhejiang Univ. —Science A –2003. — Vol. 4, № 2. —P. 236–240.
Bancroft J. Sexual desire and the brain [Text] / J. Bancroft // Sex. Marit. Ther. — 1988. — Vol. 3, Issue 1. —P. 11–27.
Buvat J. Neurotransmetteurs cerebraux et controle du comportement sexuel masculine [Text] / J. Buvat // Andrologie. — 1996. — Vol. 6, № 2. — P. 184–199.
Kaplan H. S. The New Sex Therapy [Text] / H. S. Kaplan. — N. Y.: Brunner-Routledge, 1974. — 544 p.
Corona G. Psycho-biological Correlates of Delayed Ejaculation in Male Patients With Sexual Dysfunctions [Text] / G. Corona, E. Mannuccie, L. Peyrone [et al.] // J. Androl. — 2006. —Vol. 27, № 3. —P. 453–458.
Бондаренко В. А. Роль уровня тестостерона в крови и величины индекса маскулинизации в обеспечении сексуальной функции у мужчин с препубертатным гипогонадизмом [Teкст] / В. А. Бондаренко, А. С Минухин, А. И. Гладкова // Медицинская психология. — 2006. —Т. 3, № 1. — С. 72–74.
Гладкова А. И. Гормональная регуляция мужского сексуального поведения [Teкст] / А. И. Гладкова. — Харьков, 1998. — 19 с.
Schiavi R. C. Effect of testosterone administration of sexual behavior and mood in men with erectile dysfunction [Text] / R. C. Schiavi, D. White, J. Mandeli, A. C. Levine // Arch. Sex. Behav. —1997. — Vol. 26, № 3. — P. 231–241.
Mantzoros C. S. Contribution of dihydrotestosterone to male sexual behaviour [Text] / C. S. Mantzoros, E. I. Georgiadis, D. Trichopoulos // BMJ. — 1995. — Vol. 310. —P. 1289–1291.
Cunningham G. R. Inhibition of steroid 5 alphareductase with finasteride: sleep-related erections, potency, and libido in healthy men [Text] / G. R. Cunningham, M. Hirshkowitz // J. Clin. Endocrinol. Metab. — 1995. — Vol. 80. — P. 1934–1940.
Mondaini N. Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? [Text] // N. Mondaini, P. Gontero, G. Giubilei [et al.] // J. Sex. Med. — 2007. —Vol. 4, Issue 6. — P. 1708–1712.
Canguven O. The Effect of 5 a-Reductase Inhibitors on Erectile Function [Text] / O. Canguven, A. L. Burnett // J. Androl. — 2008. — Vol. 29, № 5. — P. 514–523.
AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia. Chapter 1: Diagnosis and treatment recommendations [Text] // J. Urol. — 2003. —Vol. 170, Issue 2, Part 1. — P. 530–547.
Carbone D. J. Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life [Text] / D. J. Carbone, S. Hodges // Int. J. Impot. Res. — 2003. — Vol. 15. —P. 299–306.
Wang C. Editorial: should the nonaromatizable androgen dihydrotestosterone be considered as an alternative to testosterone in the treatment of the andropause? [Text] / C. Wang, R. C. Swerdloff // J. Clin. Endocrinol. Metab. — 2002. — Vol. 87, № 4. — P. 1462–1466.
Ly L. P. A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility and quality of life in older men with partial androgen deficiency [Text] / L. P. Ly, M. Jimenez, T. N. Zhuang // J. Clin. Endocrinol. Metab. — 2001. —Vol. 86, № 9. — P. 4078–4088.
Wright P. Hormonal correlates of human sexual arousal [Text] / P. Wright, R. Dickey // Sexual Abuse: A Journal of Research and Treatment. — 1988. — Vol. 1, № 2. — P. 319–328.
Feldman H. A. Impotence and its medical and psychological correlates: Results of the Massachusetts male aging study [Text] / H. A. Feldman, I. Goldstein, D. G. Hatzichristou [et al.] // J. Urol. — 1994. — Vol. 151. — P. 54–61.
Galich J. Serum concentration of nine hormones in aging male population and association with potency and libido problems [Text] / J. Galich, D. Imunovich // Coll. Antropol. — 2006. — Vol. 30, № 4. —P. 735–738.
Buvat J. Androgen therapy with dehydroepiandrosterone [Text] / J. Buvat // World J. Urol. — 2003. — Vol. 21, № 5. —P. 346–355.
Reiter W. J. Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study [Text] / W. J. Reiter, A. Pycha, G. Schatzl [et al.] // Urology –1999. — Vol. 53, Issue 3. —P. 590–594.
Бондаренко В. А. Особенности андрогенного статуса у мужчин с идиопатичесими патоспермиями [Teкст] / В. А. Бондаренко, В. А. Кожемяка, А. С. Минухин // Здоровье мужчины. — 2009. — № 3. — C. 175–177.
ISSN 
ISSN 
